Literature DB >> 11937621

Selection effect of needle exchange in Anchorage, Alaska.

Dennis G Fisher1, Grace L Reynolds, Colin R Harbke.   

Abstract

Participation bias (selection bias) may be a problem in studies that attempt to evaluate the effects of needle-exchange programs (NEPs). The present study looked at only those injection drug users (IDUs) who were randomly placed in the needle-exchange condition in a two-arm randomized clinical trial of needle exchange. Time to follow-up between the experimental NEP condition (n = 296; median = 261 days) and pharmacy sales condition (n = 304; median = 256 days) was not statistically different [chi(2) (1, N = 600) = 0.42, P =.52]. Within the NEP condition, a similar analysis comparing time to follow-up between IDUs who used the NEP (n = 65; median = 199 days) and those who refrained from using the NEP (n = 231; median = 286 days) was highly significant, chi(2) (1, n = 296) = 17.3, P=.0001. The final logistic regression model predicting use of the NEP was the log 10 transformation of the number of times injected heroin in the last 30 days (odds ratio [OR ]=4.9, confidence interval [CI ]2.8, 8.9), ever injected amphetamine in the last 30 days (OR =4.9, CI 1.09, 22.5), and ever shared injection equipment in the last 30 days (OR =2.9, CI 1.5, 5.5). Within the NEP condition, follow-up rates differed between those who used the NEP and those who did not use it. Of drug users randomly assigned to an NEP, the ones who actually used the NEP had higher levels of drug use. Predictors of who used the NEP were consistent with the studies of Hagen et al. This study demonstrates that selection bias occurs among IDUs who use NEPs.

Entities:  

Mesh:

Year:  2002        PMID: 11937621      PMCID: PMC3456373          DOI: 10.1093/jurban/79.1.128

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  13 in total

1.  Vaccination strategies for targeted and difficult-to-access groups.

Authors:  B N Trubatch; D G Fisher; H H Cagle; A M Fenaughty
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs.

Authors:  H Hagan; J P McGough; H Thiede; S G Hopkins; N S Weiss; E R Alexander
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

3.  The effect of syringe exchange use on high-risk injection drug users: a cohort study.

Authors:  R N Bluthenthal; A H Kral; L Gee; E A Erringer; B R Edlin
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

4.  Discriminating needle exchange attenders from non-attenders.

Authors:  M Frischer; L Elliott
Journal:  Addiction       Date:  1993-05       Impact factor: 6.526

5.  Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada.

Authors:  C P Archibald; M Ofner; S A Strathdee; D M Patrick; D Sutherland; M L Rekart; M T Schechter; M V O'Shaughnessy
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-02-01

6.  Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.

Authors:  J A Hahn; K M Vranizan; A R Moss
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-06-01

7.  Needle exchange use among a cohort of injecting drug users.

Authors:  E E Schoenbaum; D M Hartel; M N Gourevitch
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

8.  HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Authors:  D C Des Jarlais; M Marmor; D Paone; S Titus; Q Shi; T Perlis; B Jose; S R Friedman
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

9.  Syringe and needle exchange as HIV/AIDS prevention for injection drug users.

Authors:  J K Watters; M J Estilo; G L Clark; J Lorvick
Journal:  JAMA       Date:  1994-01-12       Impact factor: 56.272

10.  The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.

Authors:  E J van Ameijden; J A van den Hoek; H J van Haastrecht; R A Coutinho
Journal:  Am J Epidemiol       Date:  1992-07-15       Impact factor: 4.897

View more
  2 in total

1.  Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Authors:  Aishwarya Vijay; Alexander R Bazazi; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2015-02-18

2.  Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Authors:  Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter
Journal:  J Urban Health       Date:  2008-03-14       Impact factor: 3.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.